Search
Displaying results 11 - 11 of 11 in total
Evolocumab Action Pathway
smpdb.ca/view/SMP0125309Drug actionTherefore by inhibiting PCSK9's actions, alirocumab allows for more LDL-C reuptake by the liver and facilitates a higher rate of clearance.